Trigli LS 1mg/500mg/7.5mg Tablet SR
Marketer
Ordain Health Care Global Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Trigli LS 1mg/500mg/7.5mg Tablet SR
Metformin/Sitagliptin/Pioglitazone extended-release tablets (1mg/500mg/7.5mg) are a combined medication designed to manage blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It improves insulin effectiveness, resulting in reduced blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Take this medication with food to minimize gastrointestinal distress. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common side effects may include nausea, diarrhea, abdominal discomfort, headache, bone fractures, and respiratory infections. Patients with kidney, liver, or heart conditions should disclose this information to their doctor before commencing treatment. Pregnant or lactating women must consult their physician. Kidney function tests will be performed prior to initiating therapy. Limit alcohol consumption while taking this medicine, as it may amplify the likelihood of adverse effects.
Uses of Trigli LS 1mg/500mg/7.5mg Tablet SR
Managing type 2 diabetes
Major Benefits of Trigli LS 1mg/500mg/7.5mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consume Trigli LS 1mg/500mg/7.5mg Extended-Release tablets with food.
Common Side effects of Trigli LS 1mg/500mg/7.5mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Trigli LS 1mg/500mg/7.5mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trigli LS 1mg/500mg/7.5mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer this extended-release tablet with a meal.
How Trigli LS 1mg/500mg/7.5mg Tablet SR works:
Trigli LS 1mg/500mg/7.5mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Trigli LS 1mg/500mg/7.5mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Trigli LS 1mg/500mg/7.5mg SR tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
Use of Trigli LS 1mg/500mg/7.5mg SR tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Trigli LS 1mg/500mg/7.5mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Trigli LS 1mg/500mg/7.5mg SR tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Exercise caution when prescribing Trigli LS 1mg/500mg/7.5mg SR tablets to individuals with hepatic impairment; dosage modification may be necessary. Patients with severe liver disease should not receive this medication. Physician consultation is advised.
What if you forget to take Trigli LS 1mg/500mg/7.5mg Tablet SR :
Should you forget to take your Trigli LS 1mg/500mg/7.5mg SR Tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Trigli LS 1mg/500mg/7.5mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently